Cargando…
Effects of thrombin, PAR-1 activating peptide and a PAR-1 antagonist on umbilical artery resistance in vitro
BACKGROUND: The non-thrombotic effects of thrombin in cardiovascular tissues, as mediated via the protease activated receptors (PARs), and particularly PAR-1, have been the focus of much recent research. The aims of this study were to evaluate the effects of thrombin, a specific PAR-1 activating pep...
Autores principales: | O'Loughlin, Aonghus J, O'Sullivan, Crochan J, Ravikumar, Nandini, Friel, Anne M, Elliott, John T, Morrison, John J |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2005
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC554978/ https://www.ncbi.nlm.nih.gov/pubmed/15730558 http://dx.doi.org/10.1186/1477-7827-3-8 |
Ejemplares similares
-
Exploring the Phe-Gly Dipeptide-Derived Piperazinone Scaffold in the Search for Antagonists of the Thrombin Receptor PAR1
por: Valdivielso, Ángel M., et al.
Publicado: (2014) -
Thrombin-mediated activation of PAR1 enhances doxorubicin-induced cardiac injury in mice
por: Grover, Steven P., et al.
Publicado: (2022) -
Effects of intermittent hypoxia with thrombin in an in vitro model of human brain endothelial cells and their impact on PAR-1/PAR-3 cleavage
por: Zolotoff, Cindy, et al.
Publicado: (2022) -
The Emerging Role of the Thrombin Receptor (PAR-1) in Melanoma Metastasis - a Possible Therapeutic Target
por: Villares, Gabriel J., et al.
Publicado: (2011) -
Thrombin induces morphological and inflammatory astrocytic responses via activation of PAR1 receptor
por: Chen, Xiaojun, et al.
Publicado: (2022)